Login to Your Account



Industry: Proposals to IP regime in Australia would harm innovation

By Tamra Sami
Staff Writer

Friday, January 20, 2017

PERTH, Australia – Proposed recommendations to update Australia's intellectual property (IP) system would be disastrous to the biopharma industry and would put a stranglehold on innovation and investment, industry stakeholders said.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription